מונטהלוקאסט אינובמד 5 מ"ג

Negara: Israel

Bahasa: Ibrani

Sumber: Ministry of Health

Bahan aktif:

MONTELUKAST AS SODIUM 5 MG

Tersedia dari:

INOVAMED LTD

Kode ATC:

R03DC03

Bentuk farmasi:

CHEWABLE TABLETS

Rute administrasi :

PER OS

Diproduksi oleh:

SYNTHON B.V., NETHERLANDS

Kelompok Terapi:

MONTELUKAST

Indikasi Terapi:

Montelukast Inovamed is indicated in pediatric patients 6 to 14 years of age for the prophylaxis and chronic treatment of asthma including prevention of daytime and nighttime symptoms the treatment of aspirin-sensitive asthmatic patients and the prevention of exercise-induced bronchoconstriction.Montelukast Inovamed is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. Montelukast Inovamed and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. Montelukast Inovamed is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and pediatric patients 6 to 14 years of age.

Tanggal Otorisasi:

2012-01-01